Home › Tumor sa Utak › Virginia
Pag-aaral pangklinika para sa Tumor sa Utak sa Virginia
15 pag-aaral para sa Tumor sa Utak ang naghahanap ng mga kalahok sa mga site sa Virginia.
Mga Lungsod sa Virginia
Opisyal na teksto ng pag-aaral (English)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Inova Schar Cancer Institute, Fairfax
- VCU Massey Comprehensive Cancer Center, Richmond
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566C-SMART vs BE Well for Patients With Brain Tumors
- Virginia Commonwealth University, Richmond
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07224503Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NEXT Virginia, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05786924FearLess in NeuroOncology
- Virginia Commonwealth University, Richmond
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06989086Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Virginia Cancer Institute, Norfolk
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05386108A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06253871A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Inova Center for Personalized Health, Fairfax
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07428616A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
- Next Oncology -Virginia, Fairfax
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06136884Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- INOVA Health, Fairfax
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04427384Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- University of Virginia Comprehensive Cancer Center, Charlottesville
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Hul 21, 2026 · NCT04348747Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
- University of Virginia, Charlottesville
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 4, 2026 · NCT06810336Sonodynamic Therapy in Patients With Recurrent GBM
- University of Virginia, Charlottesville
Nagre-recruitPhase 1
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT06039709Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NEXT Virginia, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06810544S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Augusta Health Center for Cancer and Blood Disorders, Fishersville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT03418961A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- NEXT Virginia, Fairfax
Nagre-recruitPhase 1/2
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Ago 19, 2025 · NCT06907043Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.